Epilepsy affects an estimated 50 million people worldwide, making it one of the most common neurological disorders—and one of the most unevenly treated. While many individuals achieve good seizure control with medication, a substantial proportion does not have access, particularly in low- and middle-income regions. Even in well-resourced settings, drug resistance and treatment side effects … Continue reading Epilepsy and the Microbiome: From Mechanisms to Potential Therapies